Therapeutic Endovascular Embolization for Intracranial Meningioma

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatment methods. Endovascular embolization may be used in selected cases as a preoperative adjunct to reduce intraoperative bleeding. There is a need for more treatment options in patients with meningioma, both in uncomplicated, asymptomatic cases and in more complex cases. The aim of this study is to assess radiological and clinical results of therapeutic endovascular embolization for meningioma

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Radiological diagnose of typical intracranial meningioma (homogenous contrast enhancement or dural attachment)

• Indication for treatment due to growth, symptoms or both

• Tumor location suggestive of vascular supply via middle meningeal artery branches

• Age 18 years or older

• Karnofsky performance status of 90 or better (able to carry on normal activity and work)

Locations
Other Locations
Norway
St Olavs Hospital
RECRUITING
Trondheim
Contact Information
Primary
Ole Solheim, PhD
ole.solheim@ntnu.no
+4772575256
Time Frame
Start Date: 2022-10-10
Estimated Completion Date: 2037-08
Participants
Target number of participants: 30
Treatments
Experimental: Endovascular embolization
Related Therapeutic Areas
Sponsors
Leads: St. Olavs Hospital

This content was sourced from clinicaltrials.gov